PDF herunterladen
Synlett 2007(18): 2792-2796  
DOI: 10.1055/s-2007-990955
LETTER
© Georg Thieme Verlag Stuttgart · New York

One-Pot Synthesis of Highly Functionalized Oxindoles under Swern Oxidation Conditions

Pilar López-Alvarado, Judith Steinhoff, Sonia Miranda, Carmen Avendaño, J. Carlos Menéndez*
Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain
Fax: +34(91)3941822; e-Mail: josecm@farm.ucm.es;
Weitere Informationen

Publikationsverlauf

Received 1 March 2007
Publikationsdatum:
19. Oktober 2007 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

The reaction of indole derivatives bearing a 3- or 4-hydroxyalkyl chain with dimethyl sulfoxide and oxalyl chloride under Swern conditions led to a one-pot process involving three different synthetic transformations, namely oxidation of indole to oxindole, introduction of a chlorine substituent at the oxindole C-3 position, and substitution of the hydroxyl group in the side chain by chlorine. In spite of its mechanistic complexity, this synthetically useful process proceeded in good to excellent overall yield.

Key words

indoles - Swern reaction - oxindole synthesis - halogenation - oxidation

    References and Notes

  • 1 Tokunaga T. Hume WE. Nagamine J. Kawamura T. Taiji M. Nagata R. Bioorg. Med. Chem. Lett.  2005,  15:  1789 
    CrossrefGoogle Scholar
  • 2a Smith CD. Zilfou JT. Stratmann K. Patterson GML. Moore RE. Mol. Pharmacol.  1995,  47:  241 
    Google Scholar
  • 2b Zhang X. Smith CD. Mol. Pharmacol.  1996,  49:  288 
    Google Scholar
  • 3 Zaveri NT. Jiang F. Olsen CM. Deschamps JR. Parrish D. Polgar W. Toll L. J. Med. Chem.  2004,  47:  2973 
    CrossrefGoogle Scholar
  • 4 Alcaraz M. Atkinson S. Cornwall P. Foster AC. Gill DM. Humphries LA. Keegan PS. Kemp R. Merifield E. Nixon RA. Noble AJ. O’Beirne D. Patel ZM. Perkins J. Rowa P. Sadler P. Singleton JT. Tornos J. Watts AJ. Woodland IA. Org. Process Res. Dev.  2005,  9:  555 
    CrossrefGoogle Scholar
  • 5 Kikuchi C. Hiranuma T. Koyama M. Bioorg. Med. Chem. Lett.  2002,  12:  2549 
    CrossrefGoogle Scholar
  • 6 Gallagher G. Lavanchi PG. Wilson JW. Hieble JP. DeMarinis RM. J. Med. Chem.  1985,  28:  1533 
    CrossrefGoogle Scholar
  • For early surveys of oxindole alkaloids, see:
  • 7a Cordell GA. An Introduction to Alkaloids: A Biogenetic Approach   Wiley-Interscience; New York: 1981. 
    Google Scholar
  • 7b Bindra JS. Oxindole Alkaloids, In The Alkaloids - Chemistry and Physiology   Vol. 14:  Manske RHF. Academic Press; New York: 1973.  p.83 
    Google Scholar
  • 8 Abourriche A. Abboud Y. Maoufoud S. Mohou H. Seffaj T. Charrouf M. Chaib N. Benamara A. Bontemps N. Francisco C. Farmaco  2003,  58:  1351 
    CrossrefGoogle Scholar
  • 9a Isolation: Cui CB. Kakeya H. Okada G. Onose R. Osada H. J. Antibiot.  1996,  49:  527 
    CrossrefGoogle Scholar
  • 9b Structure: Cui C. Kakeya H. Osada H. Tetrahedron  1996,  52:  12651 
    CrossrefGoogle Scholar
  • Total syntheses:
  • 9c Edmonson S. Danishefsky SJ. Angew. Chem. Int. Ed.  1998,  37:  1138 
    CrossrefGoogle Scholar
  • 9d Wang H. Ganesan A. J. Org. Chem.  2000,  65:  4685 
    CrossrefGoogle Scholar
  • 9e Sebahar PR. Williams RM. J. Am. Chem. Soc.  2000,  122:  5666 
    CrossrefGoogle Scholar
  • 9f Von Nussbaum F. Danishefsky SJ. Angew. Chem. Int. Ed.  2000,  39:  2175 
    CrossrefGoogle Scholar
  • 9g Cytotoxic activity: Edmondson SE. Danishefsky SJ. Sepp-Lorenzino L. Rosen N. J. Am. Chem. Soc.  1999,  121:  2147 
    CrossrefGoogle Scholar
  • For reviews of the chemistry of the welwitindolinones, see:
  • 10a Avendaño C. Menéndez JC. Curr. Org. Synth.  2004,  1:  65 
    Google Scholar
  • 10b Menéndez JC. In Bioactive Heterocycles V, In Topics in Heterocyclic Chemistry   Vol. 11:  Springer; Berlin/Heidelberg: 2007.  p.63 
    Google Scholar
  • 11a Szabo-Pusztay K. Szabo L. Synthesis  1979,  276 
    CrossrefGoogle Scholar
  • 11b Underwood R. Prasad K. Repic O. Hardtmann G. Synth. Commun.  1992,  22:  343 
    CrossrefGoogle Scholar
  • 11c Cushing TD. Sanz-Cervera JF. Williams RM. J. Am. Chem. Soc.  1993,  115:  9323 
    CrossrefGoogle Scholar
  • 12 For a review of the synthesis of 2-oxindoles, see: Karp GM. Org. Prep. Proced. Int.  1993,  25:  481 
    Google Scholar
  • 13 Bailey PD. Cochrane PJ. Irvine F. Morgan KM. Pearson DPJ. Veal KT. Tetrahedron Lett.  1999,  40:  4593 
    CrossrefGoogle Scholar
  • 14 Some of these compounds are known in the literature. See: Harrington PE. Kerr MA. Synlett  1996,  1047 
    Artikel in Thieme ConnectGoogle Scholar
  • 15 Wuest FR. Kniess T. J. Labelled Compd. Radiopharm.  2005,  48:  31 
    CrossrefGoogle Scholar
  • Compound 8a has been previously obtained in 7% yield by treatment of alcohol 6a with NCS in CH2Cl2 followed by addition of aq NH4Cl. See:
  • 18a Hino T. Miura H. Nakagawa T. Murata R. Nakagawa M. Heterocycles  1975,  3:  805 
    CrossrefGoogle Scholar
  • 18b Hino T. Miura H. Murata R. Nakagawa M. Chem. Pharm. Bull.  1978,  26:  3695 
    CrossrefGoogle Scholar
  • A related spirocyclization was observed after exposure of two N-acyltryptophan derivatives to DMSO-Ms2O at-20 °C for 5 h, which gave the corresponding five-membered spirolactones in yields of around 65% as mixtures of diastereomers. See:
  • 20a Büchi G. DeShong PR. Katsumura S. Sagimura Y. J. Am. Chem. Soc.  1979,  101:  5084 
    Google Scholar
  • For a similar reaction using a mixture of DMSO and tert-butyl bromide, see:
  • 20b Palla G. Marchelli R. Casnati G. Dossena A. Gazz. Chim. Ital.  1982,  112:  535 
    Google Scholar
  • 20c Labroo RB. Labroo VM. King MM. Cohen LA. J. Org. Chem.  1991,  56:  3637 
    Google Scholar
  • 22 Nozoye T. Shibanuma Y. Nakai T. Hatori H. Chem. Pharm. Bull.  1988,  36:  4980 
    Google Scholar
  • 23 McComas CC. Perales JB. Van Vranken DL. Org. Lett.  2002,  3:  2337 
    Google Scholar
16

Representative Experimental Procedure
To a solution of oxalyl chloride (5 equiv) in anhyd CH2Cl2 (10 mL), at -78 °C under an argon atmophere, was added DMSO (7 equiv). The solution was stirred for ca. 10 min, until effervescence ceased. A solution of alcohol 6b (350 mg, 0.77 mmol) in anhyd CH2Cl2 (3 mL) was added dropwise via cannula, and the red solution was stirred for 10 min at -78 °C. Then, Et3N (10 equiv) was added and the solution was left to warm to r.t. for 20 min, while stirred. The reaction mixture was diluted with CH2Cl2 (20 mL) and washed with sat. aq NH4Cl (3 × 20 mL). The organic layer was dried (Na2SO4) and evaporated, and the residue was purified by rapid chromatography on silica gel, eluting with PE-EtOAc mixtures (gradient from 20:1 to 5:1), to yield compound 8b (357 mg, 90%). Slower chromatographic separation may lead to considerable amounts of decomposition products, specially from hydrolysis of the terminal chloromethylene moiety.

17

Data for Representative Compounds 8
Compound 8b: IR (film on NaCl): 1731.6 (C=O), 1112.9 (C-O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.73-7.67 (m, 4 H, H-2′′,6′′), 7.50-7.35 (m, 8 H, H-5,6,3′′,4′′,5′′), 6.77 (d, 1 H, J = 7.6 Hz, H-7), 5.07 (d, 1 H, J = 14.2 Hz, CH2O), 4.90 (d, 1 H, J = 14.2 Hz, CH2O), 3.31-3.13 (m, 2 H, H-3′), 3.21 (s, 3 H, NCH3), 2.40-2.17 (m, 2 H, H-1′), 1.43-1.28 (m, 2 H, H-2′), 1.12 [s, 9 H, C(CH3)3]. 13C NMR (62.9 MHz, CDCl3): δ = 173.2 (C-2), 142.4 (C-7a), 139.1 (C-4), 135.5 (C-2′′,6′′), 133.0 (C-1′′), 130.5 (C-6), 129.9 (C-4′′), 127.8 (C-3′′,5′′), 123.2 (C-3a), 121.6 (C-5), 107.4 (C-7), 64.4 (C-3), 60.9 (CH2O), 43.6 (C-3′), 35.6 (C-1′), 27.7 (C-2′), 26.85 (NCH3), 26.75 [C(CH3)3], 19.3 [C(CH3)3]. Anal. Calcd for C29H33Cl2NO2Si: C, 66.15; H, 6.32; N, 2.66. Found: C, 65.97; H, 6.02; N, 2.36.
Compound 8d (major diastereomer, 8da; minor diastereomer, 8db): IR (film on NaCl): 1729.0 (C=O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.35-7.25 (m, 2 H, H-4,6), 7.07 (t, 1 H, J = 7.6 Hz, H-5), 6.80 (d, 1 H, J = 7.8 Hz, H-7), 3.75-3.60 (m, 1 H, H-3′), 3.18 (m, 3 H, NCH3), 2.70-2.10 (m, 2 H, H-1′), 1.80-1.35 (m, 4 H, H-2′, CH2CH3), 0.95-0.80 (m, 3 H, CH2CH3). 13C NMR (62.9 MHz, CDCl3): δ = 174.1 (CO), 143.0 (C-7a, 8da), 142.9 (C-7a, 8db), 130.7 (C-4), 129.7 (C-3a, 8da), 129.5 (C-3a, 8db), 124.6 (C-6), 124.0 (C-5, 8db), 123.9 (C-5, 8da), 109.1 (C-7), 65.1 (C-3′, 8db), 64.9 (C-3′, 8da), 64.7 (C-3), 36.8 (C-1′, 8db), 36.3 (C-1′, 8da), 33.1 (C-2′, 8db), 32.7 (C-2′, 8da), 31.8 (CH2, 8da), 31.5 (CH2, 8db), 27.1 (NCH3), 11.3 (CH2CH3). Anal. Calcd for C14H17Cl2NO: C, 58.75; H, 5.99; N, 4.89. Found: C, 58.80; H, 5.91; N, 4.99.
Compound 8g (major diastereomer, 8ga; minor diastereomer, 8gb): IR (film on NaCl): 3296.0 (NH), 1718.7 (C=O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 8.96 (s, 1 H, NH, 8ga), 8.90 (s, 1 H, NH, 8gb), 6.96 (d, 1 H, J = 2.4 Hz, H-4), 6.88 (d, 1 H, J = 8.5 Hz, H-6), 6.82 (dd, 1 H, J = 8.5, 2.4 Hz, H-7), 4.05-3.85 (m, 1 H, H-3′), 3.81 (s, 3 H, OCH3), 2.60-2.40 (m, 2 H, H-1′), 2.40-2.20 (m, 2 H, H-2′), 1.48 (d, 3 H, J = 6.5 Hz, CH3, 8ga), 1.46 (d, 3 H, J = 6.3 Hz, CH3, 8gb). 13C NMR (62.9 MHz, CDCl3): δ = 177.1 (CO), 156.3 (C-5), 141.1 (C-7a), 134.1 (C-3a, 8gb), 133.8 (C-3a, 8ga), 115.7 (C-7, 8gb), 115.5 (C-7, 8ga), 111.8 (C-4, 8ga), 111.5 (C-4, 8gb), 111.3 (C-6), 68.0 (C-3), 58.2 (C-3′, 8gb), 58.0 (C-3′, 8ga), 56.2 (OCH3), 36.9 (C-1′, 8gb), 36.5 (C-1′, 8ga), 35.1 (C-2′, 8gb), 34.8 (C-2′, 8ga), 25.7 (CH3, 8gb), 25.5 (CH3, 8ga). Anal. Calcd for C13H15Cl2NO2: C, 54.18; H, 5.25; N, 4.86. Found: C, 53.95; H, 5.12; N, 4.75.

19

Data for 3-Chloro-1-methyl-3-(3-oxobutyl)oxindole
IR (film on NaCl): 1728.2, 1717.0 (C=O) cm-1. 1H NMR (250 MHz, CDCl3): δ = 7.39 (d, 1 H, J = 7.6 Hz, H-4), 7.37 (t, 1 H, J = 7.6 Hz, H-6), 7.15 (t, 1 H, J = 7.6 Hz, H-5), 6.87 (d, 1 H, J = 7.6 Hz, H-7), 3.25 (s, 3 H, NCH3), 2.65-2.40 (m, 4 H, H-1′,2′), 2.11 (s, 3 H, COCH3). 13C NMR (62.9 MHz, CDCl3): δ = 206.9 (C-3′), 173.9 (C-2), 142.7 (C-7a), 130.8 (C-4), 129.8 (C-3a), 124.5 (C-6), 123.9 (C-5), 109.2 (C-7), 64.4 (C-3), 38.4 (C-2′), 33.2 (C-1′), 30.4 (COCH3), 27.0 (NCH3). MS: m/z = 251 [M+]. Anal. Calcd for C13H14ClNO2: C, 62.03; H, 5.61; N, 5.56. Found: C, 62.35; H, 5.81; N, 5.62.

21

Indeed, compounds 8 were not obtained when oxalyl chloride was replaced by TFAA.